|
T.RVX
|
"Bear, I have a hard time comparing your estimate with what the market...
|
|
T.RVX
|
Correct Snobei. $1.5 billion was just for ZEN-3694, not including ZCC...
|
|
T.RVX
|
I'd say $1.5 billion USD is a fair buyout for Zenith's ZEN-3694...
|
|
T.RVX
|
Yes, this news has been out for over a month now since ASH abstracts were...
|
|
V.BTI.H
|
"On the basis of xB3-001's high probability of success"...
|
|
T.RVX
|
"Waiting for what BearDown is thinking." Well wait no longer! ...
|
|
V.BTI.H
|
I'm in a very snarky mood right now. Probably won't get any likes for...
|
|
V.BTI.H
|
"we are slightly behind schedule" Did I see/hear correctly that...
|
|
T.RVX
|
"Take it easy there beardownz syndrome." That is a good one. I had...
|
|
T.RVX
|
Kooty McKootFace, I honestly don't give a flying F what you think about...
|
|
T.RVX
|
Kindvalue, your post has zero value. You are clearly just showing up here and...
|
|
T.RVX
|
Holy smokes! Those are some pretty strong statements. I can't wait for...
|
|
T.RVX
|
Let's try that again.....CKD subgroup (eGFR BDAZ
|
|
T.RVX
|
CKD subgroup (eGFR
|
|
T.RVX
|
Patience grasshopper. Thanksgiving week is not a good time to announce stuff....
|
|
T.RVX
|
If the data presented at CTAD is good, we will hear about it one way or...
|
|
T.RVX
|
G1945V, you have the times wrong. Biogen aducanumab top-line results webcast...
|
|
T.RVX
|
Plus Dr. Winblad and Dr. Zetterberg are chairing and presenting, respectively...
|
|
T.RVX
|
Completely failing with no hint of efficacy is very different than just...
|
|
T.RVX
|
I'll let you know after their webcast on Thursday Dec 5th. BDAZ
|